Sensei Biotherapeutics, Inc. (SNSE)
NASDAQ: SNSE · Real-Time Price · USD
0.4048
-0.1035 (-20.36%)
Mar 31, 2025, 2:30 PM EDT - Market open

Sensei Biotherapeutics Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019 - 2015
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019 - 2015
Selling, General & Admin
13.0418.6719.8115.827.53
Upgrade
Research & Development
18.6318.330.3821.6611.19
Upgrade
Operating Expenses
31.6636.9650.1937.4818.71
Upgrade
Operating Income
-31.66-36.96-50.19-37.48-18.71
Upgrade
Interest Expense
-0.09-0.14-0.22-0.67-1.69
Upgrade
Interest & Investment Income
2.553.621.780.8-
Upgrade
Other Non Operating Income (Expenses)
-0-1.270.250.611
Upgrade
EBT Excluding Unusual Items
-29.21-34.76-48.37-36.75-19.41
Upgrade
Merger & Restructuring Charges
--0.1---
Upgrade
Gain (Loss) on Sale of Investments
-1.06-0.22-0.62-
Upgrade
Gain (Loss) on Sale of Assets
--0.3---
Upgrade
Asset Writedown
-0.95----
Upgrade
Other Unusual Items
---0.570.05
Upgrade
Pretax Income
-30.16-34.1-48.59-36.79-20.1
Upgrade
Earnings From Continuing Operations
-30.16-34.1-48.59-36.79-20.1
Upgrade
Net Income
-30.16-34.1-48.59-36.79-20.1
Upgrade
Preferred Dividends & Other Adjustments
----0.1
Upgrade
Net Income to Common
-30.16-34.1-48.59-36.79-20.2
Upgrade
Shares Outstanding (Basic)
252831282
Upgrade
Shares Outstanding (Diluted)
252831282
Upgrade
Shares Change (YoY)
-10.14%-8.96%10.80%1618.88%338.85%
Upgrade
EPS (Basic)
-1.20-1.22-1.58-1.33-12.53
Upgrade
EPS (Diluted)
-1.20-1.22-1.58-1.33-12.53
Upgrade
Free Cash Flow
-24.82-32.2-39.35-32.29-18.91
Upgrade
Free Cash Flow Per Share
-0.99-1.15-1.28-1.17-11.73
Upgrade
EBITDA
-30.34-35.61-48.84-36.8-18.5
Upgrade
D&A For EBITDA
1.321.351.350.690.21
Upgrade
EBIT
-31.66-36.96-50.19-37.48-18.71
Upgrade
Updated Mar 28, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q